Belinostat
Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.
Product Specifications
CAS Number
414864-00-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
318.35
Molecular Formula
C15H14N2O4S
Notes
Research use only, not for human use.
Receptor
HDAC
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog